Biofrontera (BFRI) Return on Equity [ROE] (2021 - 2026)
Biofrontera (BFRI) reported Return on Equity [ROE] of -84.41% for Q2 2026.
Powered by 
Analysis
Biofrontera (BFRI) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Biofrontera posted Return on Equity [ROE] of -141.30%, up 243.68 percentage points from FY2024.
- Return on Equity [ROE] has a four-year change of +298.09 percentage points (FY2021 to FY2025).
- By year, Return on Equity [ROE] came in at -384.98% in FY2024 (-244.55 pp), -140.43% in FY2023 (-136.79 pp), -3.63% in FY2022 (+435.76 pp) and -439.39% in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Return on Equity [ROE] since Q1 2023.
- The high point for year-over-year Return on Equity [ROE] in five years was Q2 2022 (a gain of 2089.92 percentage points); the low point was Q4 2023 (a drop of 687.73 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Biofrontera | 13.21 Mn | -7.66 Mn | 9.59 Mn | -105.85% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -105.85% |
| Mar 31, 2026 | -133.96% |
| Dec 31, 2025 | -266.77% |
| Mar 31, 2025 | -470.22% |
| Dec 31, 2024 | -356.50% |
| Sep 30, 2024 | -156.16% |
| Jun 30, 2024 | -491.72% |
| Dec 31, 2023 | -690.48% |
| Sep 30, 2023 | -644.06% |
| Jun 30, 2023 | -189.48% |
| Mar 31, 2023 | -67.34% |
| Dec 31, 2022 | -2.75% |
| Sep 30, 2022 | -62.07% |
| Jun 30, 2022 | -148.96% |
| Mar 31, 2022 | -199.05% |
| Jun 30, 2021 | -2,238.88% |
API Access
Biofrontera Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BFRI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "BFRI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BFRI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();